This Review provides insights into the physiology of GLP1 and its involvement in the pathophysiology of T2DM and an overview of the currently available and emerging GLP1RAs
P25Self-Injection Education Using Automated Digital Doctors Sen Coleman 1,2 , Caitrona Lynch 2 , Hemendra Worlikar 1 , Emily Kelly 1 , Katie Loveys 3 , Jane Walsh 1 , Elizabeth Broadbent 3 , Francis Finucane 1,2 , Derek OKeeffe 1,2 1 University of Galway, Ireland
doi:10.1093/clinchem/41.10.1509 36
10.3390/cimb47040259 19 BridiJ
Previously, Medicare only covered GLP-1 drugs prescribed for diabetes or related cardiovascular conditions, excluding most cases where obesity was the primary condition
Campana said the study has a small number of participants and was retrospective in nature